🌱 KidneyEnergy.com

Kidney research, 2026-08-17

Special olive oil may slow kidney decline in diabetes patients

Key takeaways

A diabetes trial showed that olive oil with extra oleanolic acid could help preserve kidney function. Also, hospitalizations are a major reason patients stop taking SGLT2 inhibitors.

Slowing decline · 11

Concomitant Aortic Valve Neocuspidization and Resection of a Cardiac Calcified Amorphous Tumor in a Hemodialysis Patient: A Case Report.

This case report describes two cardiac masses in a patient on hemodialysis: one mobile and one fixed. These lesions carry an embolic risk (risk of stroke or other emboli).

Paper C Peer reviewed Europe PMC, CKD · added 23 days ago

68Ga-FAPI-04 PET/CT Findings in Primary Hyperoxaluria Type 1.

This case report shows that FAPI-PET/CT can detect active fibrosis (scarring) in patients with primary hyperoxaluria type 1. This may help identify patients at risk for kidney...

Paper C Peer reviewed Europe PMC, CKD · added 23 days ago

Urine and Plasma Extracellular Vesicle Analysis for Monitoring Renal Recovery after Acute Kidney Injury.

This study used urinary and plasma-derived vesicles to track kidney injury recovery in AKI patients. These vesicles reflect the health of renal cells, but this small study cannot...

Article B Peer reviewed PubMed, CKD severity and reversal · added 23 days ago

Pendrin inhibitor PDSinh-C01 reverses salt-sensitive hypertension and metabolic acidosis in the 5/6 nephrectomy rat model.

In rats bred to have kidney disease, a drug called PDSinh-C01 lowered salt-driven high blood pressure and corrected acid buildup in the blood. The drug blocks a kidney protein...

Article D Peer reviewed PubMed, CKD nutrition RCTs · added 23 days ago

Too sweet to be true? Prophylactic SGLT2 inhibitors before cardiac surgery — NephJC

This is an online journal club post discussing a new trial. The trial tested dapagliflozin, an SGLT2 drug, to prevent sudden kidney injury after heart surgery. The post is a...

Page No results yet Not peer reviewed Forager · added 23 days ago

Combination therapy of RAS inhibition and glucagon-like peptide-1 receptor agonist improves a marker of kidney fibrosis in people with type 2 diabetes.

Researchers combined two drugs in people with type 2 diabetes: a blood pressure drug (a RAS inhibitor) and a GLP-1 drug. They measured a substance in the urine that tracks kidney...

Article C Peer reviewed PubMed, fibrosis reversal · added 23 days ago

Arterial Stiffness in Children and Young People With Hypertension and Chronic Kidney Disease

This trial looks at arterial stiffness (hardening of arteries) in children and young people with kidney disease. Arterial stiffness is a marker for cardiovascular risk, but this...

Trial B Peer reviewed ClinicalTrials.gov, CKD recruiting · added 24 days ago

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

This is an extension study for patients who completed a previous trial of zigakibart. It will monitor long-term safety in adults with IgA nephropathy.

Trial B Peer reviewed ClinicalTrials.gov, CKD recruiting · added 24 days ago

Impact of Acute Kidney Injury on Hospitalization Outcomes in Patients with Chronic Kidney Disease Undergoing Cardiac Procedures with Cardiopulmonary Bypass in the United States.

Acute kidney injury (AKI) after cardiac surgery may cause permanent damage. This study looks at risk in patients with pre-existing kidney disease.

Article B Peer reviewed PubMed, CKD progression and prevention · added 24 days ago

Therapies for Cardiovascular-Kidney-Liver-Metabolic Syndrome: Reappraisal of Fibrates.

This is a review, not a new study. Doctors took a fresh look at old cholesterol drugs called fibrates for people who have heart, kidney, liver, and blood sugar problems all at...

Article No results yet Peer reviewed PubMed, fibrosis reversal · added 23 days ago

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

This study reviewed health records of many adults with type 2 diabetes in Australia. People who were admitted to the hospital were more likely to stop taking their SGLT2 inhibitor,...

Article C Peer reviewed PubMed, the drug frontier · added 23 days ago
Nutrition & lifestyle · 2

Nephrocalcinosis Following Roux-en-Y Gastric Bypass Secondary to Suspected Enteric Hyperoxaluria: A Case Report.

Gastric bypass surgery may lead to calcium oxalate deposits in the kidney. This case report discusses risk factors for this condition.

Article C Peer reviewed PubMed, Nutritional supplements and CKD · added 24 days ago

Oleanolic Acid-Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial.

In a randomized trial, people with type 2 diabetes used olive oil enriched with oleanolic acid, a natural compound from olives. This extra analysis found their kidney filtering...

Article B Peer reviewed PubMed, CKD nutrition RCTs · added 23 days ago
Mind-body · 1

Psychological resilience trajectories and baseline factors associated with trajectory membership among patients newly initiating maintenance hemodialysis: A multicenter longitudinal study.

This study followed 693 people through their first 6 months on dialysis. It tracked how their ability to bounce back mentally, called resilience, changed over time. People fell...

Article C Peer reviewed PubMed, Lifestyle and CKD · added 23 days ago
Regeneration & devices · 2

Erastin-sensitive VDAC2 contributes to time-course peritoneal fibrosis via ferroptosis signaling induction.

In the lab, scientists studied why the lining used in peritoneal dialysis gets scarred over time. They found a form of cell death called ferroptosis, driven by a channel named...

Article D Peer reviewed PubMed, fibrosis reversal · added 23 days ago

From Risk Identification to Risk Modification in Patients With End-Stage Renal Disease Undergoing Rotational Atherectomy.

A study of 10 patients with kidney disease and heart-related artery blockages was corrected. It found that using a rotating wire to clear arteries in the kidney-damaged group led...

Paper B Peer reviewed Europe PMC, CKD · added 23 days ago
People & money · 1

Cost-effectiveness analysis comparison of etelcalcetide, paricalcitol, and cinacalcet for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

This study compared the cost and value of three drugs for overactive parathyroid glands, a common problem in kidney disease. It used a computer model of the Chinese health system...

Article No results yet Peer reviewed PubMed, Nutritional supplements and CKD · added 23 days ago